150 related articles for article (PubMed ID: 31903101)
21. Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis.
Soni MP; Shelkar N; Gaikwad RV; Vanage GR; Samad A; Devarajan PV
J Pharm Bioallied Sci; 2014 Jan; 6(1):22-30. PubMed ID: 24459400
[TBL] [Abstract][Full Text] [Related]
22. Protopine/Gemcitabine Combination Induces Cytotoxic or Cytoprotective Effects in Cell Type-Specific and Dose-Dependent Manner on Human Cancer and Normal Cells.
Garcia-Gil M; Turri B; Gabriele M; Pucci L; Agnarelli A; Lai M; Freer G; Pistello M; Vignali R; Batistoni R; Marracci S
Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33530428
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation.
Reddy LH; Vivek K; Bakshi N; Murthy RS
Pharm Dev Technol; 2006; 11(2):167-77. PubMed ID: 16749527
[TBL] [Abstract][Full Text] [Related]
24. Safranal-loaded solid lipid nanoparticles: evaluation of sunscreen and moisturizing potential for topical applications.
Khameneh B; Halimi V; Jaafari MR; Golmohammadzadeh S
Iran J Basic Med Sci; 2015 Jan; 18(1):58-63. PubMed ID: 25810877
[TBL] [Abstract][Full Text] [Related]
25. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.
Zhuang YG; Xu B; Huang F; Wu JJ; Chen S
Pharmazie; 2012 Nov; 67(11):925-9. PubMed ID: 23210242
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo antitumor activity of gemcitabine loaded thermosensitive liposomal nanoparticles and mild hyperthermia in pancreatic cancer.
Affram K; Udofot O; Cat A; Agyare E
Int J Adv Res (Indore); 2015 Oct; 3(10):859-874. PubMed ID: 26677454
[TBL] [Abstract][Full Text] [Related]
27. α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles.
Oliveira MS; Mussi SV; Gomes DA; Yoshida MI; Frezard F; Carregal VM; Ferreira LAM
Colloids Surf B Biointerfaces; 2016 Apr; 140():246-253. PubMed ID: 26764108
[TBL] [Abstract][Full Text] [Related]
28. Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells.
Lin JH; Chen SY; Lu CC; Lin JA; Yen GC
Phytother Res; 2020 Aug; 34(8):2053-2066. PubMed ID: 32185829
[TBL] [Abstract][Full Text] [Related]
29. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
[TBL] [Abstract][Full Text] [Related]
30. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
31. Preparation, Optimization and Toxicity Evaluation of (SPION-PLGA) ±PEG Nanoparticles Loaded with Gemcitabine as a Multifunctional Nanoparticle for Therapeutic and Diagnostic Applications.
Hamzian N; Hashemi M; Ghorbani M; Bahreyni Toosi MH; Ramezani M
Iran J Pharm Res; 2017; 16(1):8-21. PubMed ID: 28496458
[TBL] [Abstract][Full Text] [Related]
32. Pseudopterosin and
Xie B; Hänsel J; Mundorf V; Betz J; Reimche I; Erkan M; Büdeyri I; Gesell A; Kerr RG; Ariantari NP; Yu H; Proksch P; Teusch N; Mrsny RJ
Bioengineering (Basel); 2020 Jun; 7(2):. PubMed ID: 32545910
[TBL] [Abstract][Full Text] [Related]
33. Modulation of Epithelial-Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel.
Nakamura H; Watanabe M; Takada K; Sato T; Hikage F; Umetsu A; Muramatsu J; Furuhashi M; Ohguro H
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790973
[TBL] [Abstract][Full Text] [Related]
34. Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository.
Mohamed RA; Abass HA; Attia MA; Heikal OA
J Pharm Pharmacol; 2013 Nov; 65(11):1607-21. PubMed ID: 24102470
[TBL] [Abstract][Full Text] [Related]
35. Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agricultural application: preparation and characterization.
Lai F; Wissing SA; Müller RH; Fadda AM
AAPS PharmSciTech; 2006 Jan; 7(1):E2. PubMed ID: 16584150
[TBL] [Abstract][Full Text] [Related]
36. Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity.
Alajami HN; Fouad EA; Ashour AE; Kumar A; Yassin AEB
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057027
[TBL] [Abstract][Full Text] [Related]
37. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
[TBL] [Abstract][Full Text] [Related]
39. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling G; Yuan Z; Weigen L
Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
[TBL] [Abstract][Full Text] [Related]
40. Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models.
Oliveira MS; Aryasomayajula B; Pattni B; Mussi SV; Ferreira LAM; Torchilin VP
Int J Pharm; 2016 Oct; 512(1):292-300. PubMed ID: 27568499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
